Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

The effects of Advanced Glycation End Products (RAGE)-374T/A and Gly82Ser variants and soluble-RAGE levels to obesity in children.

Kucukhuseyin O, Ozgen T, Karagedik EH, Cesur Y, Yilmaz Aydogan H, Yaylim I, Ergen HA.

Cell Mol Biol (Noisy-le-grand). 2016 Apr 30;62(5):9-14.

PMID:
27188863
2.

Association of polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating RAGE levels.

Gaens KH, Ferreira I, van der Kallen CJ, van Greevenbroek MM, Blaak EE, Feskens EJ, Dekker JM, Nijpels G, Heine RJ, 't Hart LM, de Groot PG, Stehouwer CD, Schalkwijk CG.

J Clin Endocrinol Metab. 2009 Dec;94(12):5174-80. doi: 10.1210/jc.2009-1067. Epub 2009 Nov 4.

PMID:
19890027
3.
4.

G allele at RAGE SNP82 is associated with proinflammatory markers in obese subjects.

Kim OY, Jo SH, Jang Y, Chae JS, Kim JY, Hyun YJ, Lee JH.

Nutr Res. 2009 Feb;29(2):106-13. doi: 10.1016/j.nutres.2009.01.006.

PMID:
19285601
5.

Associations of receptor for advanced glycation end products -374 T/A and Gly82 Ser and peroxisome proliferator-activated receptor gamma Pro12Ala polymorphisms in Turkish coronary artery disease patients.

Aydoğan HY, Küçükhüseyin O, Tekeli A, Isbir T.

Genet Test Mol Biomarkers. 2012 Feb;16(2):134-7. doi: 10.1089/gtmb.2011.0077. Epub 2011 Aug 23.

PMID:
21861709
6.

The interaction between obesity and RAGE polymorphisms on the risk of knee osteoarthritis in Chinese population.

Han Z, Liu Q, Sun C, Li Y.

Cell Physiol Biochem. 2012;30(4):898-904. doi: 10.1159/000341467. Epub 2012 Sep 13.

7.

RAGE gene polymorphism and environmental factor in the risk of oral cancer.

Su S, Chien M, Lin C, Chen M, Yang S.

J Dent Res. 2015 Mar;94(3):403-11. doi: 10.1177/0022034514566215. Epub 2015 Jan 12.

8.

Soluble receptor for advanced glycation end-products (sRAGE) and polymorphisms of RAGE and glyoxalase I genes in patients with pancreas cancer.

Krechler T, Jáchymová M, Mestek O, Zák A, Zima T, Kalousová M.

Clin Biochem. 2010 Jul;43(10-11):882-6. doi: 10.1016/j.clinbiochem.2010.04.004. Epub 2010 Apr 14.

PMID:
20398646
9.

RAGE and AGEs in Mild Cognitive Impairment of Diabetic Patients: A Cross-Sectional Study.

Wang P, Huang R, Lu S, Xia W, Cai R, Sun H, Wang S.

PLoS One. 2016 Jan 8;11(1):e0145521. doi: 10.1371/journal.pone.0145521. eCollection 2016.

10.

The promoter polymorphisms of receptor for advanced glycation end products were associated with the susceptibility and progression of sepsis.

Shao Y, Shao X, He J, Cai Y, Zhao J, Chen F, Tao H, Yin Z, Tan X, He Y, Lin Y, Li K, Cui L.

Clin Genet. 2017 Apr;91(4):564-575. doi: 10.1111/cge.12800. Epub 2016 Jun 30.

PMID:
27172264
11.

Genetic polymorphisms of RAGE and risk of ulcerative colitis in a Chinese population.

Wang J, Zeng J, Wang H, Ye S, Bi Y, Zhou Y, Li K, Zhou Y.

Immunol Lett. 2016 Feb;170:88-94. doi: 10.1016/j.imlet.2015.09.003. Epub 2015 Sep 5.

PMID:
26349055
12.

Association of RAGE gene polymorphism with circulating AGEs level and paraoxonase activity in relation to macro-vascular complications in Indian type 2 diabetes mellitus patients.

Bansal S, Chawla D, Banerjee BD, Madhu SV, Tripathi AK.

Gene. 2013 Sep 10;526(2):325-30. doi: 10.1016/j.gene.2013.05.013. Epub 2013 May 27.

PMID:
23721855
13.

The functional -374T/A polymorphism of the receptor for advanced glycation end products may modulate Crohn's disease.

Däbritz J, Friedrichs F, Weinhage T, Hampe J, Kucharzik T, Lügering A, Broeckel U, Schreiber S, Spieker T, Stoll M, Foell D.

Am J Physiol Gastrointest Liver Physiol. 2011 May;300(5):G823-32. doi: 10.1152/ajpgi.00115.2010. Epub 2011 Feb 10.

14.

Receptor for advanced glycation end products (RAGE)--soluble form (sRAGE) and gene polymorphisms in patients with breast cancer.

Tesarová P, Kalousová M, Jáchymová M, Mestek O, Petruzelka L, Zima T.

Cancer Invest. 2007 Dec;25(8):720-5.

PMID:
18058469
15.

Association of RAGE (p.Gly82Ser) and MnSOD (p.Val16Ala) polymorphisms with diabetic retinopathy in T2DM patients from north India.

Vanita V.

Diabetes Res Clin Pract. 2014 Apr;104(1):155-62. doi: 10.1016/j.diabres.2013.12.059. Epub 2014 Jan 9.

PMID:
24529564
16.

Receptor for advanced glycation end products (RAGE) and glyoxalase I gene polymorphisms in pathological pregnancy.

Germanová A, Muravská A, Jáchymová M, Hájek Z, Koucký M, Mestek O, Zima T, Kalousová M.

Clin Biochem. 2012 Nov;45(16-17):1409-14. doi: 10.1016/j.clinbiochem.2012.06.031. Epub 2012 Jul 4.

PMID:
22771726
17.

Polymorphisms of the receptor for advanced glycation end-products and glyoxalase I in patients with renal cancer.

Chocholatý M, Jáchymová M, Schmidt M, Havlová K, Křepelová A, Zima T, Babjuk M, Kalousová M.

Tumour Biol. 2015 Mar;36(3):2121-6. doi: 10.1007/s13277-014-2821-0. Epub 2014 Nov 19.

PMID:
25407489
18.

The Ser82 RAGE Variant Affects Lung Function and Serum RAGE in Smokers and sRAGE Production In Vitro.

Miller S, Henry AP, Hodge E, Kheirallah AK, Billington CK, Rimington TL, Bhaker SK, Obeidat M, Melén E, Merid SK, Swan C, Gowland C, Nelson CP, Stewart CE, Bolton CE, Kilty I, Malarstig A, Parker SG, Moffatt MF, Wardlaw AJ, Hall IP, Sayers I.

PLoS One. 2016 Oct 18;11(10):e0164041. doi: 10.1371/journal.pone.0164041. eCollection 2016.

19.

Receptor for advanced glycation end products (RAGE) polymorphisms are associated with systemic lupus erythematosus and disease severity in lupus nephritis.

Martens HA, Nienhuis HL, Gross S, van der Steege G, Brouwer E, Berden JH, de Sévaux RG, Derksen RH, Voskuyl AE, Berger SP, Navis GJ, Nolte IM, Kallenberg CG, Bijl M.

Lupus. 2012 Aug;21(9):959-68. doi: 10.1177/0961203312444495. Epub 2012 Apr 18.

PMID:
22513366
20.

Soluble receptor and gene polymorphism for AGE: relationship with obesity and cardiovascular risks.

Rowisha M, El-Batch M, El Shikh T, El Melegy S, Aly H.

Pediatr Res. 2016 Jul;80(1):67-71. doi: 10.1038/pr.2016.55. Epub 2016 Mar 18.

PMID:
26991258

Supplemental Content

Support Center